Diffusion Pharmaceuticals CEO David Kalergis' 2019 pay slips 19% to $476K
Diffusion Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 29, 2020
Diffusion Pharmaceuticals reported fiscal year 2019 executive compensation information on April 29, 2020.
In 2019, three executives at Diffusion Pharmaceuticals received on average a compensation package of $412K, a 12% decrease compared to previous year.
Average pay of disclosed executives at Diffusion Pharmaceuticals
David G. Kalergis, Chief Executive Officer, received $476K in total, which decreased by 19% compared to 2018. 86% of Kalergis' compensation, or $410K, was in salary. Kalergis also received $50K in non-equity incentive plan and $16K in other compensation.
John L. Gainer, Chief Scientific Officer, received a compensation package of $404K, which decreased by 20% compared to previous year. 90% of the compensation package, or $364K, was in salary.
William K. Hornung, Chief Financial Officer, earned $355K in 2019, a 4% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 29, 2020.